Innovative Monitoring Tech Sensifree's proprietary RF-based, cuff-free blood pressure sensors offer hospitals an advanced, non-invasive solution that can replace traditional cuff-based methods, reducing patient discomfort and risk.

Growing Investment Backing With $7 million in total funding and recent Series A financing, Sensifree demonstrates strong investor confidence, supporting its expansion into clinical markets and potential sales channels.

Target Market Expansion The focus on continuous, real-time hemodynamic monitoring positions Sensifree to become a key supplier for hospitals, ICUs, and surgical centers seeking to enhance patient safety and improve monitoring efficiency.

Strategic Collaborations Partnerships with organizations like CSEM and Translink Capital highlight opportunities for joint development and market entry, making Sensifree an attractive partner for medical device distributors and healthcare providers.

Regulatory and R&D Focus Ongoing development of next-generation devices signals readiness to meet regulatory standards and scale manufacturing, paving the way for new sales opportunities in hospital procurement and medical device procurement channels.